ATE408625T1 - Sauerstofftransportierende, auf albumin basierende blutersatzzusammensetzung und blutvolumenexpender - Google Patents

Sauerstofftransportierende, auf albumin basierende blutersatzzusammensetzung und blutvolumenexpender

Info

Publication number
ATE408625T1
ATE408625T1 AT98960629T AT98960629T ATE408625T1 AT E408625 T1 ATE408625 T1 AT E408625T1 AT 98960629 T AT98960629 T AT 98960629T AT 98960629 T AT98960629 T AT 98960629T AT E408625 T1 ATE408625 T1 AT E408625T1
Authority
AT
Austria
Prior art keywords
oxygen
compositions
recombinant
heme
expender
Prior art date
Application number
AT98960629T
Other languages
English (en)
Inventor
Daniel Carter
Joseph Ho
Florian Ruker
Original Assignee
New Century Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Century Pharmaceuticals filed Critical New Century Pharmaceuticals
Application granted granted Critical
Publication of ATE408625T1 publication Critical patent/ATE408625T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0025—Culture media for plant cell or plant tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98960629T 1997-12-03 1998-12-03 Sauerstofftransportierende, auf albumin basierende blutersatzzusammensetzung und blutvolumenexpender ATE408625T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/984,176 US5948609A (en) 1997-12-03 1997-12-03 Oxygen-transporting albumin-based blood replacement composition and blood volume expander

Publications (1)

Publication Number Publication Date
ATE408625T1 true ATE408625T1 (de) 2008-10-15

Family

ID=25530365

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98960629T ATE408625T1 (de) 1997-12-03 1998-12-03 Sauerstofftransportierende, auf albumin basierende blutersatzzusammensetzung und blutvolumenexpender

Country Status (7)

Country Link
US (1) US5948609A (de)
EP (1) EP1036095B1 (de)
JP (1) JP2002500862A (de)
AT (1) ATE408625T1 (de)
AU (1) AU1618499A (de)
DE (1) DE69840030D1 (de)
WO (1) WO1999028348A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2263674T5 (es) * 2000-11-03 2011-04-01 Xvivo Perfusion Ab Disolución de evaluación y conservación .
EP1406917A4 (de) 2001-06-15 2007-11-14 New Century Pharmaceuticals Humanalbumintiermodelle für die bewertung von arzneimitteln und für toxikologie- und immunogenitätsuntersuchungen
AU2003225630A1 (en) * 2002-03-01 2003-09-16 New Century Pharmaceuticals, Inc. Atomic structure of the hemalbumin complex and its use in designing therapeutic compounds
CN101172091B (zh) * 2007-09-25 2011-04-27 北京美福源生物医药科技有限公司 含人血清白蛋白与皮肤细胞生长因子的融合蛋白护肤产品制备工艺和用途
GB0217347D0 (en) * 2002-07-26 2002-09-04 Univ Edinburgh Novel albumins
US20070219767A1 (en) * 2003-05-06 2007-09-20 Carter Daniel C Atomic coordinates of albumin drug complexes and method of use of pharmaceutical development
EP1475434A1 (de) * 2003-05-09 2004-11-10 Oncoscience AG Verfahren zur Lagerung von Tumorzellen
WO2004108890A2 (en) * 2003-05-30 2004-12-16 New Century Pharmaceuticals, Inc. Dilute methanol -or ethanol- induced production of polypeptides in microorganisms
EP1684705A4 (de) * 2003-11-03 2008-02-20 New Century Pharmaceuticals Albumin-bindungsstellen zur beurteilung von arzneimittelwechselwirkungen und verfahren zur beurteilung oder zum entwurf von arzneimitteln auf basis ihrer albuminbindungseigenschaften
JP2006045172A (ja) * 2004-08-09 2006-02-16 Hidetoshi Tsuchida 組換えヒト血清アルブミン−金属ポルフィリン錯体、人工酸素運搬体および赤血球代替物
SE0402536D0 (sv) 2004-10-20 2004-10-20 Therim Diagnostica Ab Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
US7229967B2 (en) * 2004-11-12 2007-06-12 Hunter Research Corporation Oxygenated albumin for use as blood and blood extender
EP3130602B1 (de) * 2007-05-08 2019-08-07 CanImGuide Therapeutics AB Immunregulatorische strukturen von normal auftretenden proteinen
JP5936112B2 (ja) 2009-02-11 2016-06-15 アルブミディクス アクティーゼルスカブ アルブミン変異体及び複合体
BR112012009450A2 (pt) 2009-10-30 2017-05-23 Novozymes Biopharma Dk As variantes de albumina
CN106977608A (zh) 2010-04-09 2017-07-25 阿尔布麦狄克斯公司 白蛋白衍生物和变体
JP6430828B2 (ja) * 2011-05-05 2018-11-28 アルブミディクス リミティド アルブミン変異体
EP2780364A2 (de) 2011-11-18 2014-09-24 Eleven Biotherapeutics, Inc. Proteine mit verbesserter halbwertzeit und anderen eigenschaften
US9944691B2 (en) 2012-03-16 2018-04-17 Albumedix A/S Albumin variants
GB2512156A (en) 2012-11-08 2014-09-24 Novozymes Biopharma Dk As Albumin variants
GB2532960A (en) * 2014-12-02 2016-06-08 Imp Innovations Ltd Blood filter
CN108137674B (zh) 2015-08-20 2022-12-06 阿尔布梅迪克斯医疗有限公司 白蛋白变体和缀合物
CA3047523A1 (en) 2016-12-21 2018-06-28 Prometic Biosciences Inc. Methods and compositions for preventing or minimizing epithelial-mesenchymal transition
CN114773454B (zh) * 2022-04-27 2022-11-29 广州蕊特生物科技有限公司 从马心中提取肌红蛋白的提取与纯化方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296466A (en) * 1992-02-19 1994-03-22 Board Of Regents, The University Of Texas System Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein
US5780594A (en) * 1993-03-01 1998-07-14 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Biologically active protein fragments containing specific binding regions of serum albumin or related proteins
AU685661B2 (en) * 1994-07-22 1998-01-22 Duke University Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof

Also Published As

Publication number Publication date
AU1618499A (en) 1999-06-16
EP1036095A4 (de) 2003-05-14
EP1036095A1 (de) 2000-09-20
US5948609A (en) 1999-09-07
EP1036095B1 (de) 2008-09-17
WO1999028348A1 (en) 1999-06-10
DE69840030D1 (de) 2008-10-30
JP2002500862A (ja) 2002-01-15

Similar Documents

Publication Publication Date Title
ATE408625T1 (de) Sauerstofftransportierende, auf albumin basierende blutersatzzusammensetzung und blutvolumenexpender
Winslow Red cell substitutes
BR1100732A (pt) Compostos imunossupressivos e composição
ES2137186T3 (es) Nuevos compuestos inmunosupresores.
ATE77556T1 (de) Stabilisierte humanprotein-praeparate.
AU563962B2 (en) Cysteine depleted muteins of biologically active proteins
ES2181678T3 (es) Secuencia de aadn sinteticas que tienen actividad insecticida potenciada en maiz.
ATE183514T1 (de) Peptide des menschlichen proteins p53 zum gebrauch in menschlichen-zytotoxischen-t-zell- antwort-induzierenden kompositionen sowie menschliche p53-protein-spezifische t-lymphocyten
EP0422125A4 (en) Platelet blocking peptides
Stowell Hemoglobin-based oxygen carriers
ATE107665T1 (de) Proteaseresistenter pdgf und dessen verwendungen.
DK0444186T3 (da) Farmaceutisk præparat, som gør celler, der udtrykker MHC klasse II-antigener, til mål for cytotoksiske T-celler
KR970706840A (ko) 성장호르몬 및 발린으로 이루어진 약학적 조성물(a pharmaceutical formulation comprising a growth hormone and valine)
KR900701181A (ko) 식품의 보존 방법
DK0495047T3 (da) Stabil hæmoglobinbaseret komposition og fremgangsmåde til opbevaring deraf
KR870005014A (ko) 사독(蛇毒) 성장정지 펩티드 및 그 수득 및 정제방법
DE60030960D1 (de) Lösungen für die organtransplantation enthaltend konjugate von löslichen peptidischen verbindungen mit membranbindenden wirkstoffen
EP0524737A3 (en) Protein s. polypeptides and anti-peptide antibodies that inhibit protein s binding to c4b binding protein, diagnostic systems and therapeutic methods
Finney et al. Hb NEWCASTLE: 092 (FS) His+ Pro
KR890000109A (ko) 세포막의 안정화 방법 및 세포 표면 항원보호를 위한 이의 적용
Yoo et al. Identification of Ser-543 as the major regulatory phosphorylation site in spinach leaf nitrate reductase
EP0367554A3 (de) Insulinbindende Wirkstoffe und Hemmer der Insulinbindung
NO931696L (no) Erytrocytter og trombo-erytrocytter som maal-spesifikke midler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee